Looking to expand your partner network with leading companies like Oxford Sciences Innovation? Consider joining Inpart's global network for free.
News and Trends 17 Feb 2020
UK Biotech Closes €50M Series A for GPCR Drug Discovery
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted development of drugs targeting G protein-coupled receptors. OMass Therapeutics’s Series A initially raised €17M in late 2018. The new funds bring this up to €50M (£41.5M). Investors in the most recent fundraise included the UK VC firm Syncona — which […]